http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104630219-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104630219-B |
| titleOfInvention | SaRNA molecule of tumor suppressor gene IRX1 and combinations thereof and its application |
| abstract | The present invention relates to drug fields, specifically, the present invention relates to saRNA molecules of a tumor suppressor gene IRX1 and combinations thereof and its application.The invention discloses the saRNA molecules of a tumor suppressor gene IRX1, it is characterised in that its sequence is complementary with the more than IRX1 gene promoter offset transcription initiation site sequence SEQ ID NO:1 in -1781 to -2930 regions, increases the expression of IRX1 gene.Present invention firstly discovers that the saRNA molecule of tumor suppressor gene IRX1, it can tumor suppressor gene IRX1 that effectively activating cancer inactivates into the cell, with the biological effectiveness for inhibiting cancer cell multiplication, new method and recruit's target spot are provided for the gene therapy of tumour, the targeted therapy new strategy of split tumor of swelling is of great significance, and has potential clinical value. |
| priorityDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.